Calliditas Therapeutics
CALTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010441584 (+1 more)
- LEI:
- 549300PVPZO8TNT76B58
- Country:
- Sweden
- Address:
- Box 70351, 107 24 Stockholm
- Website:
- https://www.calliditas.se/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Calliditas is dedicated to expanding treatment options and establishing new standards of care for people with rare diseases. By drawing on our expertise in pharmaceutical product development and leveraging our strategic partnerships, we quickly and efficiently identify, develop, and market a pipeline of innovative medicines that can improve the lives of patients. Recently, we successfully commercialized our lead candidate in the United States, and in collaboration with our partners, launched in Europe, with plans to seek approval in Asia.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-09-16 15:30 |
Delisting Announcement
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
|
English | 134.8 KB | |
| 2024-09-16 15:30 |
Delisting Announcement
Avnotering av Calliditas Therapeutics AB (publ) från Nasdaq Stockholm
|
Swedish | 134.6 KB | |
| 2024-08-13 07:00 |
Interim Report
|
Swedish | 2.0 MB | |
| 2024-08-13 07:00 |
Interim Report
|
English | 2.0 MB | |
| 2024-08-06 11:00 |
Major Shareholding Notification
|
English | 34.7 KB | |
| 2024-08-05 13:51 |
Major Shareholding Notification
|
English | 34.5 KB | |
| 2024-07-31 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Calliditas Therapeutics
|
Swedish | 180.0 KB | |
| 2024-07-31 14:00 |
Share Issue/Capital Change
Number of shares and votes in Calliditas Therapeutics
|
English | 120.7 KB | |
| 2024-07-26 08:00 |
Earnings Release
Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliar…
|
English | 219.4 KB | |
| 2024-07-26 08:00 |
Regulatory News Service
Calliditas utläser positiva topline-data från fas 2b-studien TRANSFORM i primär…
|
Swedish | 223.3 KB | |
| 2024-06-17 17:30 |
Post-Annual General Meeting Information
Kommuniké från årsstämman i Calliditas Therapeutics AB (publ)
|
Swedish | 158.0 KB | |
| 2024-06-17 17:30 |
Post-Annual General Meeting Information
Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
|
English | 141.0 KB | |
| 2024-06-04 10:15 |
Major Shareholding Notification
|
English | 34.1 KB | |
| 2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA får positivt yttrande från CHMP som rekommenderar ett …
|
Swedish | 176.3 KB | |
| 2024-05-30 20:00 |
Legal Proceedings Report
Calliditas partner STADA receives positive CHMP opinion recommending full appro…
|
English | 177.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-23 | Diane Parks | Other | Other | 4,086 | N/A |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 36,000 | 7,408,800.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Sell | 31,439 | 6,476,434.00 SEK |
| 2024-07-04 | Fredrik Johansson | Other | Buy | 40,939 | N/A |
| 2024-07-03 | Frank Bringstrup | Other | Sell | 8,000 | 1,646,400.00 SEK |
| 2024-07-02 | Richard Philipson | Other | Sell | 27,209 | 5,591,177.41 SEK |
| 2024-07-02 | Frank Bringstrup | Other | Sell | 9,796 | 2,012,980.04 SEK |
| 2024-07-02 | Sandra Boström Frithiof | Other | Sell | 6,530 | 1,341,849.70 SEK |
| 2024-07-01 | Richard Philipson | Other | Sell | 23,676 | 4,866,838.56 SEK |
| 2024-07-01 | Frank Bringstrup | Other | Sell | 8,523 | 1,751,987.88 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyfuse Biomedical K.K. | Japan | 4892 | |
|
DAIICHI SANKYO COMPANY, LIMITED | Japan | 4568 | |
|
Daito Pharmaceutical Co., Ltd. | Japan | 4577 | |
|
DanCann Pharma A/S | Denmark | DANCAN | |
|
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH | |
|
Delta-Fly Pharma, Inc. | Japan | 4598 | |
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT | |
|
D.Western Therapeutics Institute, Inc. | Japan | 4576 |